The AIR2 Trial is no longer recruiting patients.

A new path may be opening for asthma sufferers.

ASTHMA INTERVENTION RESEARCH 2 TRIAL

The AIR2 Trial is a research study of an investigational outpatient procedure aimed at evaluating its safety and efficacy in patients with severe asthma. The procedure is called Bronchial Thermoplasty and uses thermal energy to reduce the airway smooth muscle in the lung in hopes of reducing the airways ability to constrict. Less constriction in the airways may result in reducing the severity and frequency of asthma symptoms.

Twenty million people in the United States and an estimated 300 million people around the world suffer from Asthma.

Asthma is a common disease in which the airways in the lung become inflamed, excess airway mucus is produced, and airways narrow when muscles within the airway walls contract.

If you have asthma, are between 18 and 70 years of age, are a non-smoker, and take medication daily to control your asthma, you may be eligible to participate in a future study of bronchial thermoplasty. We have no ongoing studies at this time, and our devices are not available for sale.
For more information on participation in future clinical studies please complete our information request form here, or call 408-419-0123.

CAUTION: The Alair® System is an Investigational device. It is limited by United States law to investigational use. To be used by Qualified Investigators only.